Soluble exon-9-mutated CRT is highly released from ER of tumor cells to further inhibit phagocytosis by DCs and induce immunosuppressive effects in osteosarcoma, cervix adenocarcinoma, fibrosarcoma and NSCLC [126]. The gene discussed is CALR; the disease is neoplasm.